Testing effectiveness (Phase 2)Study completedNCT02199496
What this trial is testing
Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Who this might be right for
Gastrointestinal Inflammation Associated With CVIDCVID Enteropathy
National Institute of Allergy and Infectious Diseases (NIAID) 5